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ABSTRACT
Clinical use of cefadroxil, particularly in Bangka Tengah Hospital, is proven beneficial to
overcome mild to moderate infections which especially occur in soft tissues such as skin, upper
respiratory tract, pharyngitis, tonsillitis and urinary tract. For this reason, it is necessary to procure
cefadroxil to be available enough for the treatment of cases of these diseases. The cefadroxil used
by the Central Bangka Hospital was obtained from several pharmaceutical industries with
different prices and distributions, due to the possibility that the active raw materials and
ingredients had different origins, so there was concern that the microbiological quality would be
different. Drug procurement is carried out using the e-catalog or non-e-catalog method. This study
aimed to examine the microbiological quality of six preparations (A, B, C, D, E, and F) in terms
of their inhibitory activities against Gram-positive and Gram-negative bacteria. The bioassay was
carried out by diffusion agar method using Escherichia coli ATCC 29522 and Staphylococcus
aureus ATCC 29523 as the bacterial test, and nutrient agar as the test medium. The inhibitory
activities were compared to cefadroxil standard for measuring the ratio potency. The results
showed that all samples fulfilled USP 41 requirements with potential ratio of 90% to 120% and
minimum inhibitory concentration of ≤ 8 ppm and ≤ 2 ppm against Escherichia coli and
Staphylococcus aureus respectively. The potency ratios to cefadroxil standard were 95.9%, 99.1%,
100.0%, 96.7%, 96.2% and 98.2% against Staphylococcus aureus while the potency ratios of
95.6%, 99.3%, 103.8%, 97.1%, 95.7% and 100.4% were achieved against Escherichia coli for A,
B, C, D, E, and F samples, respectively.
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______________________________________________________________________________
INTRODUCTION
Cefadroxil belongs to the first generation
of cephalosporins besides cephradine,
cephalexin, cefazoline, cephapirin and
cephalothin. In Indonesia, the first generation
of cephalosporin preparations available and
included in the National Formulary are
cefadroxil and cephalexin whereas only one e-
catalog namely e-katalog.lkpp.go.id is
included in the e-catalog system. Cefadroxil is
prescribed for the treatment of mild to
moderate infections in soft tissues such as skin,
upper respiratory tract, pharyngitis, tonsillitis
and urinary tract with a dose of 500 to 1000
mg/day (Brayfield, 2014; Micromedex, 2018).
The use of cefadroxil capsules in the first level
health facilities (FKTP-Fasilitas Kesehatan
Tingkat Pertama) is very limited (Kemenkes,
2017).
The number of planned drug requirements
(RKO-Rencana Kebutuhan Obat) in Bangka
Belitung Islands provincial health office for
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cefadroxil capsules is still high, reaching
294,804 in 2018 (Dinkes, 2018). The price of
cefadroxil per 500 mg capsule in the e-catalog
for government procurement and BPJS since
2018 is Rp488, which is valid from January
10th, 2018, until April 3rd, 2021 (LKPP, 2018).
The price is far different from what is
written on the Decree of the Minister of Health
of the Republic of Indonesia Number
094/Menkes/SK/II/2012, regarding the price
of medicines for government procurement in
2012 which was Rp840. This price for the
government was already lower than the
Highest Retail Price (HET) in the same year.
Based on the Government Regulation of the
Republic of Indonesia Number 32 of 1991
(Anonymous, 1991) concerning import of raw
materials, cefadroxil is one of those
commodities that is allowed to be imported.
Cefadroxil price reduction of more than
41% by the Government Goods and Services
Procurement Policy Agency in 2018 compared
to 2012 prices forced pharmaceutical
wholesalers (PBF-Pedagang Besar Farmasi)
to reduce relevant fees, especially in shipping
drugs to users. Direct procurement of drugs to
the pharmaceutical industry can be done
through e-purchasing systems. The industry
appoints PBF to approve a purchase contract.
Large price reductions triggered a concern
over the quality of drugs (Dwiaji et al., 2016).
The microbiological activity test on six brands
of cefadroxil capsules consumed by patients in
Bangka Belitung Hospital is a strategic step to
ensure the safety of the drug before it reaches
the patient. This research is an experimental
study to examine in vitro differences among
the six different cefadroxil capsules purchased
through e-catalogs and non-e-catalogs (LKPP,
2018; MIMS Indonesia, 2018). Significant
price differences of the drugs between those
obtained through e-catalog and non-e-catalog
may indicate differences in quality as well,
especially in their microbiological quality.
Therefore, this study was conducted to ensure
that there were no differences in
microbiological quality between the products.
MATERIALS AND METHODS
Antibiotics
The six 500 mg cefadroxil capsule
samples were obtained from both e-catalog
and non-e-catalog. The e-catalog cefadroxil
samples were purchased from the Pharmacy
Installation Division and Central Bangka
District Hospital, Bangka Belitung Province
while the non-e-catalog ones were obtained
from the Central Bangka Regency Hospital.
Each sample was collected for as many as 100
capsules with the same batch number to
compare the pharmaceutical grades of
cefadroxil (PT. New Interbat),
Dimethylsulfoxidep.a (Merck).
Test bacteria
Staphylococcus aureus ATCC 25923 and
Escherichia coli ATCC 29522 (Letter of
statement No 115/301.25/XI/2018) were
obtained from the Laboratory of Clinical
Microbiology, Dr. Soetomo Hospital. Sodium
chloride 0.9% was used for preparation of the
test bacteria. Spectrophotometer Termo
Fischer Scientific Type Genesys 20 was used
to measure optical density (580 nm) of the test
bacteria suspension to obtain 25% T (CLSI,
2015).
Preparation of test media
Mueler Hinton agar and broth (Difco)
were used for antibacterial activity assays.
Three grams of media powder was added with
150 mL distilled water, heated while stirring
evenly, and sterilized with an autoclave at
120oC for 15 minutes. Media poured in petri
dishes at 40oC to 50oC were then left solid to
be used as a base layer. Seed layer media were
prepared by inoculating a 5 µL 25% (258 nm)
T test microbial suspense containing 109 CFU
and poured over the surface of the compacted
media layer (ICH, 2005).
Minimum inhibitory concentration
In vitro antibacterial activity was
evaluated using agar diffusion method on the
Muller Hinton agar using a hole as reservoir.
The minimum inhibitory concentration (MIC)
was determined by a serial dilution on Muller
Hinton broth media containing serial of
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twofold a test solution. The MIC was
measured after 18 to 22 hours of incubation at
35 + 1oC.
Potency ratio of antibiotics
The ratio of antibiotic potential in the
sample to the cefadroxil standard was
measured by a 3-3 design according to
Farmakope Indonesia-III (Kemenkes, 1979).
Three levels of test on samples and three
levels of standard namely higher (H), medium
(M), and lower (L) concentration solutions
were achieved. The tests were carried out
using agar diffusion method with a hole as
reservoir. Statistical analysis of the data
obtained was performed by one-way ANOVA
from block random design.
RESULTS AND DISCUSSION
The inhibition of measurement of the
sample solution and cefadroxil standard was
carried out in a petri dish to obtain the same
condition with negative control or DMSO used
as a solvent (Figure 1). The minimum
inhibitory concentration (MIC) was
determined based on the smallest level that
can inhibit the growth of test bacteria
compared to positive control from cefadroxil
standard (Table 1). Determination of the MIC
was useful for setting lower concentration in
determining the ratio of antibiotic potential
(Table 2 and 4) to the standard. The lower
concentration (L) should be higher than the
MIC value.
Table 1. Average of minimum inhibition concentration of six samples against S. aureus and E. coli
Test Bacteria Minimum Inhibitory Concentration (µg/mL)
A B C D E F
E. coli 8 8 8 8 8 8
S. aureus 2 2 2 2 2 2
Figure 1. In vitro inhibitory activity of cefadroxil standard (G), samples A, B, C, D, E, F and DMSO (X) after
incubation 18 to 22 hours at 35+1oC on Muller Hinton agar media, S. aureus as a test bacteria (ppm=µg/mL).
Note: in the DMSO also created a table in the MIC value, so that readers can see clearly since DMSO can also
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Development and validation of a
microbiological method for determination of
cefadroxil capsules by turbidimetry using S.
aureus as the test bacteria and brain heart
infusion broth as the sulture medium in 3×3
parallel line assay design reported by De
Marco and Salgado (2018) showed
satisfactory results. The method was proven to
be linear, selective, precise, robust and
accurate based on ICH (2005) guidelines in a
concentration range of 30 to 120 μg mL−1. The
developed turbidimetric method is a valid,
simple, fast and more economical alternative
methodology especially for the routine quality
control of cefadroxil in its pharmaceutical
dosage form (USP 41, 2018).
The values of turbidity of positive control
from cefadroxil reference standard were 0.567
and 0.527 against S. aureus and E. coli
respectively. The MIC values obtained in this
study were 8 µg/mL and 2 µg/mL against E.
coli and S. aureus respectively. The value of
MIC against E. coli was ≤ 8 µg/mL meaning
that the bacteria were still sensitive. A value of
16 µg/mL indicates intermediate and a value
of ≥ 32 means resistant (CLSI, 2015; USP 41,
2018). The bacteria used were standardized
strains, so that all bacteria were sensitive to
test antibiotics. Calculation of the potency
ratio began with the observation of inhibition
zones formed around the logging after
incubation for 18 to 22 hours at 35 + 1oC at
low (L), medium (M) and high (H)
concentrations for both test samples and
standard solutions (3-3 design) according to
Farmakope Indonesia-III (Kemenkes, 1979).
Comparison of H:M must be the same as M:L.
The results of the zone diameter measurements
(Table 2 and Table 4) were calculated with the
ANOVA random block design, showing a
non-significant difference for all samples at
p>0.05 (Table 3 and Table 5).
Table 2. Growth inhibitory activity against E. coli
Replication Cons. Growth Inhibition Zone Diameter (mm)
A B C D E F G
1 H 18.8+0.6 18.8 +0.8 19.1 +0.8 18.2 +1.0 18.9 +0.5 19.2 + 0.9 19.7 +0.5
M 13.8 +0.8 15.2 +0.8 14.2 +1.4 14.2 +1.0 13.8 +1.2 15.2 + 1.7 15.0 +1.1
L 11.6 +0.6 11.9 +1.0 12.0 +0.7 11.5 +1.0 11.0 +0.9 11.9 + 0.9 11.0 +1.1
2 H 19.2 +1.2 18.8 +0.7 19.0 +1.1 19.9 +0.7 18.7 +1.1 18.7 + 1.1 20.3 +0.4
M 14.0 +0.8 15.2 +0.8 15.5 +0.8 14.1 +1.0 14.1 +1.6 14.7 + 1.6 15.1 +1.0
L 11.6 +0.8 11.8 +0.9 12.2 +1.1 11.2 +0.9 11.5 +0.9 11.5+ 0.9 10.0 +0.9
3 H 18.9 +0.8 18.6 +0.5 19.0 +0.8 18.8 +1.2 19.5 +0.9 18.7 + 0.9 19.5 +0.5
M 14.0 +0.9 15.3 +0.9 15.5 +0.8 14.6 +1.3 14.2 +0.9 14.9 + 1.5 14.8 +0.9
L 11.8 +0.5 12.0 +1.1 12.1 +1.2 11.9 +0.9 11.3+0.7 11.6+ 1.2 11.0+1.1
Total 45.0 +2.6 45.9 +1.5 44.9 +2.7 45.3 +2.2 45.3 +2.8 46.9 + 3.0 45.5 +2.5
p >0.05 >0.05 >0.05 >0,.05 >0.05 >0.05 >0/05
H = Higher conc. (600 µg/mL), M = Medium conc. (300 µg/mL), L= Lower conc. (150 µg/mL); A, B, C, D, E,
F = product codes, G = cefadroxil standard
Table 3. Recapitulation statistical analysis by one-way ANOVA against E. coli
Product A B C D E F STD
A 0.558 0.273 0.999 1 0.842 0.633
B 0.558 0.999 0.842 0.697 0.999 1
C 0.273 0.999 0.558 0.391 0.965 0.997
D 0.999 0842 0.558 1 0.979 0.891
E 1 0.697 0.391 1 0.925 0.766
F 0.842 0.999 0.965 0.979 0.925 1
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Table 4. Growth inhibitory activity against S. aureus
Replicat
ion
Cons. Growth Inhibition Zone Diameter (mm)
A B C D E F G
1 H 18.9 + 0.7 19.5 + 0.3 19.6 +0.5 17.6 +0.7 18.8 +0.7 19.3 + 1.1 18.8 + 1.1
M 13.6 + 0.5 14.7 + 0.6 14.7 +1.1 14.7 +0.3 13.7 +0.3 15.5 + 1.6 14.8 + 1.6
L 11.2 + 1.2 11.7 + 1.0 12.4 +0.9 12.8 +1.3 11.5 +0.5 12.0 + 1.1 10.8 + 0.8
2 H 18.5 + 1.1 19.1 + 0.6 19.1+1.1 18.6 +0.6 19.4 +0.8 19.2 + 1.0 20.0 + 0.9
M 14.9 + 0.2 14.6 + 0.5 17.5 +0.7 14.2 +1.1 14.0 +1.2 14.9 + 1.6 15.1 + 1.4
L 11.5 + 1.0 12.0 + 0.2 13.7 +1.4 12.2 +0.7 11.5 +1.0 11.8 + 1.0 11.3 + 1.1
3 H 18.4 + 0.6 18.5 + 0.8 18.9 +0.6 18.1 +1.0 18.7 +0.9 18.8 + 1,3 20.3 + 0,6
M 13.6 + 0.9 14.9 + 0.4 14.0 +1.4 14.3 +1.1 13.8 +1.3 14.8 + 1.6 15.2 + 1.3
L 11.6 + 0.6 11.6 + 1.2 11.8 +0.9 11.5 +1.0 11.0 +0.9 11.7 + 0.7 11.0 + 1.0
Total 43.9 + 1.9 44.6 + 1.4 43.9 +1.6 44.4 +1.6 44.3 +2.0 45.6 + 1.7 45.8 + 3.2
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
H = Higher conc. (600 µg/mL), M = Medium conc. (300 µg/mL), L = Lower conc. (150 µg/ml) A, B, C, D, E, F
= product codes, G = cefadroxil standard
Table 5. Recapitulation statistical analysis by one-way ANOVA against S.aureus
Product A B C D E F G
A 0,489 0,002 0,985 1 0,192 0,305
B 0,489 0,328 0,927 0,546 0,998 1
C 0,002 0,328 0,024 0,002 0,677 0,517
D 0,985 0,927 0,024 0,992 0,654 0,799
E 1 0,546 0,002 0,020 0,228 0,352
F 0,192 0,998 0,677 0,654 0,228 1
Table 6. Ratio of potency between antibiotic in the six samples and cefadroxil standard against S. aureus and E. coli
Test Bacteria Potency Ratio of Samples and Cefadroxil Standard (%)
A B C D E F
E. coli 95.9 99.1 100.0 96.7 96.2 98.2
S. aureus
95.6 99.3 103.8 97.1 95.7 100.4
The inhibition of all samples against E.
coli was the same while the inhibition against
S. aureus for several samples showed
different meanings (Table 3 and Table 5).
The mean value of inhibition zone diameter
against E. coli from sample D with the
highest cefadroxil concentration (H) showed
the smallest diameter of 18.2 + 1.0 mm. The
inhibition zone diameter of E. coli was
smaller than the diameter of the inhibition
zone against S. aureus with the cefadroxil
test solution at the same concentration. This
phenomenon occurs due to differences in the
wall structure of Gram-positive and Gram-
negative bacteria. The structure of Gram-
positive bacterial walls is single-layered and
Gram-negative is multi-layered (multi)
during the mechanism of action of cefadroxil
through inhibition of cell wall synthesis
(Grayson et al., 2018). Antibiotics were
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categorized as sensitive with a 30 µg well
hole if it has a diameter value of ≥ 18 mm,
intermediate if the diameter value is 15 to 17
mm, and resistant if it is ≤ 14 mm (CLSI,
2015).
The results of the calculation of the
potential ratio compared to the standard were
according to Farmakope Indonesia-III
(Kemenkes, 1979). Referring to Table 6, it
can be concluded that potential ratios were
declared to meet USP 41 (2018)
requirements which specify acceptance
criteria of cefadroxil capsule potentials for
not less than 90% and greater than 120%.
The potential ratio compared to the
cefadroxil standard (G) generated the values
of 95.9% to 100.0% and 95.6% to 103.8%
(Table 6) against E. coli and S. aureus
respectively. The 500 mg cefadroxil capsules
that were tested indicated that all samples
met the standard of both potential ratio and
MIC. This finding indicated that the drugs
distributed at the health center or puskesmas
and Bangka Tengah Hospital met the
requirements. Drugs procured by e-
purchasing are in principle safer than
counterfeiting because they are carried out
by procurement officers directly to the
desired pharmaceutical industry. So, those
who make agreements or contracts are not
PBF. Drugs that have been announced on the
e-purchasing system have gone through
administrative selection especially related to
eligibility requirements (LKPP, 2018).
Research on the potency of
microbiological and chemical content of
active substances of some cefadroxil
capsules has never been done in Indonesia.
Meanwhile, in Pakistan there has been a
study comparing the microbiological
potential of six cefadroxil capsules using S.
aureus and E. coli germ isolates (Rahim et
al., 2014) and content examination by HPLC
(Rahim et al., 2015). Rahim et al. (2013)
also reported that seven brands of cefadroxil
monohydrate have been evaluated using set
quality control test of weight variation,
hardness, disintegration, dissolution and
assay with the intention to judge whether
these seven brands are pharmaceutically
equivalent with USP standard.
CONCLUSION
The potential ratio of the six cefadroxil
500 mg capsule brands to the cefadroxil
standard meets USP 41 requirements.
Minimum inhibitory concentration of all six
brands of cefadroxil capsule products is the
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